Versant Capital Management, Inc - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 195 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$686
+18.7%
600.0%0.00%
Q3 2023$578
-56.2%
60
-51.6%
0.00%
Q2 2023$1,319
+109.0%
124
+106.7%
0.00%
Q1 2023$631
-15.1%
600.0%0.00%
Q4 2022$743
-25.7%
600.0%0.00%
Q3 2022$1,0000.0%60
-33.3%
0.00%
Q2 2022$1,0000.0%900.0%0.00%
Q1 2022$1,0000.0%90
+50.0%
0.00%
Q4 2021$1,0000.0%600.0%0.00%
Q3 2021$1,0000.0%600.0%0.00%
Q2 2021$1,0000.0%600.0%0.00%
Q1 2021$1,000600.0%0.00%
Q4 2020$0600.0%0.00%
Q3 2020$0600.0%0.00%
Q2 2020$060
-25.0%
0.00%
Q1 2020$0
-100.0%
80
-14.0%
0.00%
-100.0%
Q4 2019$1,0000.0%93
-31.1%
0.00%
Q3 2019$1,0000.0%135
+3.8%
0.00%
Q2 2019$1,000
-50.0%
130
-11.6%
0.00%
Q1 2019$2,0001470.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders